Capha Pharmaceuticals Inc.
FPSUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $33 | $26 | $29 | $29 |
| SG&A Expenses | $51 | $53 | $58 | $44 |
| Sales & Mktg Exp. | $18 | $27 | $28 | $15 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $51 | $53 | $58 | $44 |
| Operating Income | -$51 | -$53 | -$58 | -$45 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$20 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$71 | -$53 | -$58 | -$45 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$71 | -$53 | -$58 | -$45 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | -37.5% | 11.1% | -28.6% | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 64,456 | 64,478 | 64,431 | 64,431 |
| Weighted Avg Shares Out Dil | 64,431 | 64,431 | 64,431 | 64,431 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$51 | -$53 | -$58 | -$44 |
| % Margin | – | – | – | – |